Navigation Links
HPS Files Patent for Mood-Enhancing Compound Naturally Found in Sea Coral
Date:12/17/2008

SAN JOSE, Calif., Dec. 17 /PRNewswire-FirstCall/ -- Human Pheromone Sciences, Inc. (OTC Bulletin Board: EROX) ("HPS" or "the Company") announced that it has filed a Comprehensive Patent Application with the U.S. Patent and Trademark Office for the use of an innovative and previously undeveloped compound with its origin in sea coral, which has significant emotional impacts on both men and women, enhancing feelings of positive social relationships, personal well-being and social attraction.

"We are very excited about the potential of this naturally-occurring compound that we have labeled ER 303. Just inhaling very small quantities resulted in enhanced feelings of confidence, relaxation, affection, warmth, satisfaction and sensuality, in both men and women," a spokesperson indicated. Before the Company perfected the reproduction of this compound, it could only be found in coral reefs off the coasts of Newfoundland and in the waters off Brazil's Guiabinha Island.

"The Patent Application covers use in a wide range of products that may be enhanced and differentiated by the addition of ER 303, including those in the cosmetics and fragrance, personal care, environmental and household fields. Before filing for patent protection, the Company and its scientists have worked for more than eight years from the initial identification, reproducing the compound in the laboratory, conducting psychological and physiological scientific studies with men and women volunteers, and developing a manufacturing process for broad-scale production," the spokesperson also noted. The Company indicated that it is in the process of establishing http://www.ER303.com as its website which will contain additional information about the ER 303 technology and its potential applications for consumer product companies.

The Company has previously been granted broad-based worldwide patents for
'/>"/>

SOURCE Human Pheromone Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. AMERIGROUP Files Shelf Registration Statement
2. PreMD Files Provisional Patent Application Describing a New Method of Quantifying Cancer Biomarkers
3. Bally Total Fitness Files for Chapter 11 Bankruptcy Protection
4. Aduromed Files Patent Application to Cover Proprietary New Standard for Containerized, Turnkey Solution
5. China West II Files Suit Against Genesis Pharmaceuticals and Capital Research Group Inc, Announces Conference Call Details
6. Hagens Berman Files Class Action Against Bayer Healthcare Over Misleading Marketing Campaign
7. VisiVite.com Files for Patent on Unique Macular Degeneration Supplement
8. State Fund Files an 8.9 Percent Premium Increase for 2009
9. KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10-Q
10. Genesis Pharmaceuticals Files Counter Claims
11. Mary Hall, CEO of iHealthSpot, Inc., is Awarded Membership Into Fort Lauderdale City Limits "Profiles of Excellence"

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)....Y., Nov. 6 The Leukemia &...g in Gap Inc.,s Give & Get program, which in i..., garnered more than $1 million to support LLS,s b... and support services. ,, During the campaign, ...will issue downloadable 30% discount coupons p...
(Date:11/6/2009).... 6 The U.S. bishops se...tatives November 6, as House members steeped thems...n and the health care reform bill. ,, Moments b...e bill, the bishops called for "a fair process" th...p in place current federal law on abortion funding...
(Date:11/6/2009)...ree leading scientific organizations specializing ...to President Obama today expressing their signific...ng the use of personal protective equipment (PPE) ...firmed cases of 2009 H1N1 influenza. The Society...e Infectious Diseases Society of America (IDSA) an...
(Date:11/6/2009)...s seem to wane as years go by, researcher says , ...research suggests that people with multiple sclero...ing the disease are more likely to suffer from sev... the condition. , The findings, published Nov. ...e who relapse within five years of developing it a...
(Date:11/6/2009)... WAVonline - the Value-Added Distributor to Of... Product Lines , (PRWEB) ...tributor of wireless, security, RFID, VoIP and por... has partnered with Vecima Networks Inc. (TSX:VCM)...band access to cable, wireless and telephony netwo...
Breaking Medicine News(10 mins):Health News:Get a Jump on Your Holiday Shopping and Give Two Gifts This Season: One to Your Loved Ones and One to People Battling Blood Cancer 2Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 2Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 3Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 4Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 5Health News:Prevention experts urge modification to 2009 H1N1 guidance for health care workers 2Health News:Early Relapse of MS May Mean Fewer Issues Later 2Health News:WAV Distribution Partners with Vecima Networks Inc. 2Health News:WAV Distribution Partners with Vecima Networks Inc. 3
...agents and,employees will be queuing up in the nex... a new company initiative to boost the rolls of th...arrow program kicks off at the company,s annual,na...ordinator in Boston, whose stem cell donation rece...
... have shed more light on the mechanism that regula...ess in which a methyl group is attached to DNA, th..., DNA methylation is essential for normal growth ... as cancer. , In the UO,s Institute of Molecular ...
...ny families are,economizing on groceries but one t...about 25 cents per 8-ounce glass, on a gallon basi...t any other beverage option in the,supermarket -- ...y lists, the National got milk? Campaign is shinin...
...gras,was a college student finishing up another ye...nt faced with having one of her fingers removed. ,...iddle finger. Bigras, 19, was,in a state of shock ...than the traumatic events of the cancer,diagnosis,...
...at up about how best to improve the U.S. health ca...largest health insurers has an innovative program ...ice Corporation (HCSC), which operates the Blue Cr...ven successful in four key areas: decreasing in-pa...
...the upscale,men,s magazine from health and fitness...ogram(TM) from Posit Science(R) as the best comput...rveyed the field, researched eight programs,tested... points. , The ranking appears as part of an...
Other Medicine News:Health News:Aflac Agents and Employees Boost Bone Marrow Registry 2Health News:Aflac Agents and Employees Boost Bone Marrow Registry 3Health News:Work with fungus uncovering keys to DNA methylation 2Health News:Milk is One Beverage Houston Can't Afford to Keep Off the Grocery List 2Health News:Milk is One Beverage Houston Can't Afford to Keep Off the Grocery List 3Health News:Music Therapy Helps Relieve Anxiety, Emotions of Cancer Diagnosis 2Health News:Music Therapy Helps Relieve Anxiety, Emotions of Cancer Diagnosis 3Health News:Health Care Service Corporation Finds Success With Innovative Program Targeting Obesity Epidemic 2Health News:Health Care Service Corporation Finds Success With Innovative Program Targeting Obesity Epidemic 3Health News:Posit Science is Best in Brain Fitness Says Best Life 2
(Date:11/6/2009)...FirstCall/ -- Virtual Health Technologies, Inc. (O...previously confirmed Letter of Intent to sell all ...hnologies, Inc (WNDM) is subject to final approval...GI. ,, Shareholder Assurances ,, "We bel...ream and cash realized from the transaction would ...
(Date:11/6/2009)...Call/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ),...t of small-molecule therapeutics for the treatment...(HIV), today reported recent accomplishments and f...nths ended September 30, 2009. ,, (Logo: htt...O ) ,, "Since our last quarterly update, we hav...
(Date:11/6/2009)...ll/ -- Cyberonics, Inc. (Nasdaq: CYBX ) today ann...lts for the second quarter ended October 23, 2009 ...day, November 18, 2009 at 5:00 PM EST. The compan...results on Thursday, November 19, 2009 at 9:00 AM ...ts Conference Call Instructions ,, To listen ...
Breaking Medicine Technology:OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 3OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Sinovac Obtains Second Order of H1N1 Vaccine from Chinese Central Government 58512 1Sinovac Obtains Second Order of H1N1 Vaccine from Chinese Central Government 58512 2Sinovac Obtains Second Order of H1N1 Vaccine from Chinese Central Government 58512 3MacuSight 28R 29 Provides Clinical Development Update for Perceiva 28TM 29 14292 1MacuSight 28R 29 Provides Clinical Development Update for Perceiva 28TM 29 14292 2MacuSight 28R 29 Provides Clinical Development Update for Perceiva 28TM 29 14292 3MacuSight 28R 29 Provides Clinical Development Update for Perceiva 28TM 29 14292 4MacuSight 28R 29 Provides Clinical Development Update for Perceiva 28TM 29 14292 5InteKrin Therapeutics Presents Positive INT131 Phase 2b Results at the 45th Annual European Association for the Study of Diabetes Meeting 14290 1InteKrin Therapeutics Presents Positive INT131 Phase 2b Results at the 45th Annual European Association for the Study of Diabetes Meeting 14290 2
SureSigns VS1 Vital Signs Monitor
... continuous monitoring, the M3 and M4 monitors off...onatal patient care. M Series monitors are equippe...basic set of non-invasive parameters and input for...Measurement Server extensions offer Mainstream or ...
...lp (OLEH), an interactive electronic textbook, pro...ted information. OLEH brings clinical decision sup...ost right on the patient monitor screen while tak... reduction and greater efficiencies with practical...
MP30
Medicine Products: